Skip To Main Content
Yinxu Zhao on Muck Rack

Yinxu Zhao

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinxu

Contact Yinxu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents through a Mitochondria-Mediated Apoptotic Pathway

|
By Siqi Deng, Yinxu Zhao, Xiaoshan Guo, Xian Hong
| MDPI
1. Introduction Cancer is the leading cause of death and has a serious impact on human health worldwide [1,2]. Chemotherapy is a traditional method for treating cancer [3]. However, despite the effectiveness of chemotherapeutic drugs, they can also cause adverse reactions in normal cells and are associated with multidrug resistance (MDR) [4]. Therefore, it is urgent to develop more effective drugs with low toxicity.
Open in Who Shared Issue with article?

Lupeol-3-carbamate Derivatives: Synthesis and Biological Evaluation as Potential Antitumor Agents

|
By Shuang Tian, Siqi Deng, Liman Hou, Yinxu Zhao
| MDPI
1. Introduction Cancer is recognized as one of the most lethal diseases affecting humans, with its annual incidence and mortality rates continuing to be high [1]. At present, a variety of anti-tumor drugs are being developed and applied in clinical practice. Despite clinical use, many anti-tumor drugs are known to have serious side effects, such as those caused by traditional platinum-based anticancer drugs [2,3]. Their broader use is limited due to toxicity and potential drug resistance.
Open in Who Shared Issue with article?
See all 2 articles